Federated Hermes’s Gamida Cell Ltd. Ordinary Shares GMDA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-1,547,600
Closed -$2M 2296
2022
Q4
$2M Buy
1,547,600
+9,252
+0.6% +$14.6K 0.01% 913
2022
Q3
$2.45M Sell
1,538,348
-330,548
-18% -$754K 0.01% 858
2022
Q2
$3.31M Sell
1,868,896
-3,259,404
-64% -$8.28M 0.01% 794
2022
Q1
$21.3M Buy
5,128,300
+764,985
+18% +$2.56M 0.05% 424
2021
Q4
$11.1M Sell
4,363,315
-323,250
-7% -$1.06M 0.02% 616
2021
Q3
$18.4M Hold
4,686,565
0.04% 491
2021
Q2
$30M Hold
4,686,565
0.06% 386
2021
Q1
$37.9M Sell
4,686,565
-365,958
-7% -$3.36M 0.07% 340
2020
Q4
$42.4M Buy
5,052,523
+3,274,746
+184% +$22.2M 0.09% 288
2020
Q3
$7.38M Hold
1,777,777
0.02% 646
2020
Q2
$8.12M Buy
+1,777,777
New +$8.16M 0.02% 597

Other funds holding GMDA

Federated Hermes's GMDA Position: Q1 2023 in Review

Federated Hermes sold out of Gamida Cell Ltd. Ordinary Shares (GMDA) in Q1 2023, closing a stake of 1,547,600 shares — an estimated $2M sold.

Federated Hermes first reported a position in GMDA in Q2 2020 and held it in 11 quarters. The position peaked at $42.4M in Q4 2020. 44 funds tracked by Wall St. Rank hold GMDA as of Q1 2023.

  • Federated Hermes reported no remaining Gamida Cell Ltd. Ordinary Shares position as of Q1 2023 after selling out during the quarter.
  • Federated Hermes sold 1,547,600 Gamida Cell Ltd. Ordinary Shares shares in Q1 2023, an estimated $2M.
  • Federated Hermes first reported a position in Gamida Cell Ltd. Ordinary Shares in Q2 2020 and held it in 11 quarters.
  • Federated Hermes's Gamida Cell Ltd. Ordinary Shares position peaked at $42.4M in Q4 2020.
  • 44 funds tracked by Wall St. Rank held Gamida Cell Ltd. Ordinary Shares as of Q1 2023.

Based on Federated Hermes's 13F filing for Q1 2023, filed 8 May 2023.